A detailed history of Voya Investment Management LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 883,817 shares of BCRX stock, worth $6.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
883,817
Previous 846,844 4.37%
Holding current value
$6.69 Million
Previous $5.23 Million 28.36%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.41 - $8.69 $236,996 - $321,295
36,973 Added 4.37%
883,817 $6.72 Million
Q2 2024

Dec 03, 2024

SELL
$4.13 - $6.79 $152,698 - $251,046
-36,973 Reduced 4.18%
846,844 $5.23 Million
Q2 2024

Aug 14, 2024

SELL
$4.13 - $6.79 $629,709 - $1.04 Million
-152,472 Reduced 15.26%
846,844 $5.23 Million
Q1 2024

Dec 06, 2024

BUY
$4.89 - $7.65 $564,790 - $883,567
115,499 Added 13.07%
999,316 $5.08 Million
Q1 2024

May 15, 2024

BUY
$4.89 - $7.65 $844,498 - $1.32 Million
172,699 Added 20.89%
999,316 $5.08 Million
Q4 2023

Feb 14, 2024

SELL
$4.98 - $6.77 $503,154 - $684,006
-101,035 Reduced 10.89%
826,617 $4.95 Million
Q3 2023

Nov 14, 2023

BUY
$6.71 - $7.92 $958,476 - $1.13 Million
142,843 Added 18.2%
927,652 $6.57 Million
Q2 2023

Aug 14, 2023

BUY
$6.96 - $8.81 $1.26 Million - $1.59 Million
180,398 Added 29.85%
784,809 $5.53 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $11.84 $1.29 Million - $1.93 Million
-162,604 Reduced 21.2%
604,411 $5.04 Million
Q4 2022

Feb 14, 2023

BUY
$10.5 - $14.2 $1.46 Million - $1.97 Million
138,987 Added 22.13%
767,015 $8.81 Million
Q3 2022

Mar 03, 2023

SELL
$10.79 - $14.81 $1.5 Million - $2.06 Million
-138,987 Reduced 18.12%
628,028 $7.91 Million
Q3 2022

Nov 14, 2022

BUY
$10.79 - $14.81 $635,304 - $871,997
58,879 Added 10.35%
628,028 $7.91 Million
Q2 2022

Aug 15, 2022

BUY
$7.89 - $17.88 $3.91 Million - $8.86 Million
495,483 Added 672.61%
569,149 $6.02 Million
Q1 2022

May 16, 2022

BUY
$11.56 - $19.76 $27,327 - $46,712
2,364 Added 3.32%
73,666 $1.2 Million
Q4 2021

Feb 14, 2022

BUY
$11.18 - $15.46 $23,299 - $32,218
2,084 Added 3.01%
71,302 $987,000
Q3 2021

Nov 15, 2021

SELL
$14.21 - $17.65 $20,618 - $25,610
-1,451 Reduced 2.05%
69,218 $995,000
Q2 2021

Aug 16, 2021

SELL
$9.5 - $17.24 $66,129 - $120,007
-6,961 Reduced 8.97%
70,669 $1.12 Million
Q1 2021

May 17, 2021

BUY
$7.37 - $13.61 $7,141 - $13,188
969 Added 1.26%
77,630 $789,000
Q4 2020

Feb 16, 2021

BUY
$3.37 - $8.61 $60,275 - $153,998
17,886 Added 30.43%
76,661 $571,000
Q3 2020

Nov 16, 2020

BUY
$3.43 - $5.53 $19,962 - $32,184
5,820 Added 10.99%
58,775 $202,000
Q2 2020

Aug 14, 2020

SELL
$1.9 - $5.61 $47,604 - $140,558
-25,055 Reduced 32.12%
52,955 $252,000
Q1 2020

May 15, 2020

BUY
$1.6 - $4.11 $9,235 - $23,722
5,772 Added 7.99%
78,010 $156,000
Q4 2019

Feb 14, 2020

BUY
$1.59 - $3.45 $42,356 - $91,904
26,639 Added 58.42%
72,238 $249,000
Q4 2018

Feb 14, 2019

BUY
$6.51 - $9.6 $22,407 - $33,043
3,442 Added 8.16%
45,599 $368,000
Q4 2017

Feb 14, 2018

BUY
$4.16 - $5.33 $16,149 - $20,691
3,882 Added 10.14%
42,157 $207,000
Q3 2017

Nov 14, 2017

BUY
$4.1 - $5.97 $156,927 - $228,501
38,275
38,275 $201,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.